| Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes S Mueller, T Engleitner, R Maresch, M Zukowska, S Lange, ... Nature 554 (7690), 62-68, 2018 | 371 | 2018 |
| PiggyBac transposon mutagenesis: a tool for cancer gene discovery in mice R Rad, L Rad, W Wang, J Cadinanos, G Vassiliou, S Rice, LS Campos, ... Science 330 (6007), 1104-1107, 2010 | 289 | 2010 |
| Aging and chronic DNA damage response activate a regulatory pathway involving miR‐29 and p53 AP Ugalde, AJ Ramsay, J De La Rosa, I Varela, G Mariño, J Cadiñanos, ... The EMBO journal 30 (11), 2219-2232, 2011 | 274 | 2011 |
| CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice J Weber, R Öllinger, M Friedrich, U Ehmer, M Barenboim, K Steiger, I Heid, ... Proceedings of the National Academy of Sciences 112 (45), 13982-13987, 2015 | 217 | 2015 |
| Prelamin A causes progeria through cell-extrinsic mechanisms and prevents cancer invasion J de La Rosa, JMP Freije, R Cabanillas, FG Osorio, MF Fraga, ... Nature communications 4 (1), 2268, 2013 | 92 | 2013 |
| PiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in mice J Weber, J de la Rosa, CS Grove, M Schick, L Rad, O Baranov, A Strong, ... Nature Communications 10 (1), 1415, 2019 | 50 | 2019 |
| A single-copy Sleeping Beauty transposon mutagenesis screen identifies new PTEN-cooperating tumor suppressor genes J De La Rosa, J Weber, MJ Friedrich, Y Li, L Rad, H Ponstingl, Q Liang, ... Nature genetics 49 (5), 730-741, 2017 | 49 | 2017 |
| Novel germline CDKN2A mutation associated with head and neck squamous cell carcinomas and melanomas R Cabanillas, A Astudillo, M Valle, J de la Rosa, R Álvarez, NS Durán, ... Head & neck 35 (3), E80-E84, 2013 | 35 | 2013 |
| PiggyBac mutagenesis and exome sequencing identify genetic driver landscapes and potential therapeutic targets of EGFR-mutant gliomas I Noorani, J de la Rosa, YH Choi, A Strong, H Ponstingl, MS Vijayabaskar, ... Genome biology 21, 1-36, 2020 | 25 | 2020 |
| CRISPR and transposon in vivo screens for cancer drivers and therapeutic targets I Noorani, A Bradley, J de la Rosa Genome biology 21 (1), 204, 2020 | 18 | 2020 |
| Disentangling PTEN-cooperating tumor suppressor gene networks in cancer J de la Rosa, J Weber, R Rad, A Bradley, J Cadiñanos Molecular & Cellular Oncology 4 (4), e1325550, 2017 | 12 | 2017 |
| Luminescence-based in vivo monitoring of NF-κB activity through a gene delivery approach FG Osorio, J de la Rosa, JMP Freije Cell Communication and Signaling 11, 1-6, 2013 | 12 | 2013 |
| Novel germline SDHD deletion associated with an unusual sympathetic head and neck paraganglioma J Cadinanos, JL Llorente, J de la Rosa, JA Villameytide, R Illán, ... Head & neck 33 (8), 1233-1240, 2011 | 4 | 2011 |
| Breaking barriers for glioblastoma with a path to enhanced drug delivery I Noorani, J de la Rosa nature communications 14 (1), 5909, 2023 | 2 | 2023 |
| Correction to: PiggyBac mutagenesis and exome sequencing identify genetic driver landscapes and potential therapeutic targets of EGFR-mutant gliomas I Noorani, J de la Rosa, YH Choi, A Strong, H Ponstingl, MS Vijayabaskar, ... Genome biology 21, 1-2, 2020 | | 2020 |
| High-throughput functional screening for PTEN-cooperating tumour suppressor networks in prostate cancer J de la Rosa, A Bradley FEBS OPEN BIO 9, 402-402, 2019 | | 2019 |
